EGFR activating mutations detected by different PCR techniques in Caucasian NSCLC patients with CNS metastases: short report

EGFR mutation testing has become an essential determination to decide treatment options for NSCLC. The mutation analysis is often conducted in samples with low percentage of tumour cells from primary tumour biopsies. There is very little evidence that samples from metastatic tissues are suitable for...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kamila, Wojas-Krawczyk, Michał, Skroński, Paweł, Krawczyk, Paulina, Jaguś, Tomasz, Kucharczyk, Bożena, Jarosz, Radosław, Mlak, Justyna, Szumiło, Marek, Sawicki, Trojanowski, Tomasz, Janusz, Milanowski, Joanna, Chorostowska-Wynimko
Format: Artigo
Langue:Inglês
Publié: Springer Netherlands 2013
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3841581/
https://ncbi.nlm.nih.gov/pubmed/23892415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10585-013-9603-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires